Waldenström Macroglobuloinemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Waldenström Macroglobuloinemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07471074

Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia

Waldenström disease (WM) is defined by the presence of bone marrow lymphoplasmocytes and monoclonal immunoglobulin M (IgM). Treatment should be initiated in cas…

France50 participantsStarted 2026-02-10

Treatment: sample of bone marrow cells

Waldenström Macroglobuloinemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia

All recent trials (1 shown)